Foresite Capital Management V, LLC Diversified Active

Name: Foresite Capital Management V, LLC Q1 2026 13F Filing | 13F Explorer
Creator: Foresite Capital Management V, LLC
Published: 2026-05-15

Location: West Hollywood, CA

CIK: 0001792206 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $271M (100.0% shares, 0.0% debt)

Holdings (9)

New Positions (3)

EIKN Eikon Therapeutics, Inc. 5.1%

Value $13.95M Shares 1,318,983 Est. Cost $10.58 Unrealized —

PHVS Pharvaris N.V. 2.0%

Value $5.484M Shares 194,125 Est. Cost $26.74 Unrealized 0.0%

NRIX Nurix Therapeutics, Inc. 1.5%

Value $4.107M Shares 265,000 Est. Cost $17.34 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
EIKN	Eikon Therapeutics, Inc.	1,318,983	$13.95M	5.1%	$10.58	—	COM	282564103
PHVS	Pharvaris N.V.	194,125	$5.484M	2.0%	$26.74	0.0%	COM	N69605108
NRIX	Nurix Therapeutics, Inc.	265,000	$4.107M	1.5%	$17.34	0.0%	COM	67080M103

Increased Positions (3)

ALMS ALUMIS INC. 47.9%

Value $130M (+130.3%) Shares 5,896,995 (+2.0%) Est. Cost $13.41 Unrealized +81.4%

HIMS Hims & Hers Health, Inc. 5.7%

Value $15.32M (+72.8%) Shares 738,151 (+170.2%) Est. Cost $19.07 Unrealized +32.8%

IRON Disc Medicine, Inc. 8.8%

Value $23.92M (+0.7%) Shares 374,069 (+25.1%) Est. Cost $52.30 Unrealized +41.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALMS	ALUMIS INC.	5,896,995 (+2.0%)	$130M (+130.3%)	47.9%	$13.41	+81.4%	COM	022307102
HIMS	Hims & Hers Health, Inc.	738,151 (+170.2%)	$15.32M (+72.8%)	5.7%	$19.07	+32.8%	COM CL A	433000106
IRON	Disc Medicine, Inc.	374,069 (+25.1%)	$23.92M (+0.7%)	8.8%	$52.30	+41.6%	COM	254604101

Exited Positions (1)

NTRA Natera, Inc. 5.7%

Value $15.43M Shares 67,356 Est. Cost $208.59 Unrealized +8.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NTRA	Natera, Inc.	67,356	$15.43M	5.7%	$208.59	+8.3%	—	632307104

Decreased Positions (1)

MAZE Maze Therapeutics, Inc. 0.3%

Value $773K (-78.4%) Shares 25,905 (-70.0%) Est. Cost $12.04 Unrealized +265.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MAZE	Maze Therapeutics, Inc.	25,905 (-70.0%)	$773K (-78.4%)	0.3%	$12.04	+265.8%	COM	578784100

Unchanged Positions (2)

CGON CG Oncology, Inc. 25.1%

Value $67.95M Shares 1,004,050 Est. Cost $36.31 Unrealized +44.4%

LYEL Lyell Immunopharma, Inc. 3.5%

Value $9.57M Shares 477,078 Est. Cost $9.45 Unrealized +157.4%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG Oncology, Inc.	1,004,050	$67.95M	25.1%	$36.31	+44.4%	COM	156944100
LYEL	Lyell Immunopharma, Inc.	477,078	$9.57M	3.5%	$9.45	+157.4%	COM	55083R203